Cochran John 4
4 · Aquestive Therapeutics, Inc. · Filed Mar 16, 2021
Insider Transaction Report
Form 4
Cochran John
Director
Transactions
- Other
Common Stock
2021-03-12+11,544→ 117,895 total - Other
Common Stock
2021-03-12+19,091→ 136,986 total - Other
Common Stock
2021-03-12+23,038→ 98,123 total - Other
Common Stock
2021-03-12+8,228→ 106,351 total
Footnotes (1)
- [F1]Pro rata distributions for no consideration of shares of common stock of the Issuer by the following entities, respectively (collectively, the "Distributing Entities"): MonoLine Rx, L.P., MonoLine Rx III, L.P., MonoSol Rx Genpar, L.P., and MRX Partners, LLC. The Reporting Person under this Form 4 possesses no voting or investment control over the securities held by the Distributing Entities.